Published in Ann Oncol on January 09, 2013
Drugs, cancer and end-of-life care: a case study of pharmaceuticalization? Soc Sci Med (2014) 2.03
Quantification of harms in cancer screening trials: literature review. BMJ (2013) 1.77
Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate. PLoS Biol (2013) 1.33
Declaration of transparency for each research article. BMJ (2013) 1.27
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence. Br J Cancer (2014) 1.25
Comparison of registered and published outcomes in randomized controlled trials: a systematic review. BMC Med (2015) 1.01
Making randomised trials more efficient: report of the first meeting to discuss the Trial Forge platform. Trials (2015) 0.97
Classification and prevalence of spin in abstracts of non-randomized studies evaluating an intervention. BMC Med Res Methodol (2015) 0.91
'Spin' in published biomedical literature: A methodological systematic review. PLoS Biol (2017) 0.84
Interpretation of Results of Studies Evaluating an Intervention Highlighted in Google Health News: A Cross-Sectional Study of News. PLoS One (2015) 0.82
Assessing the Eventual Publication of Clinical Trial Abstracts Submitted to a Large Annual Oncology Meeting. Oncologist (2016) 0.80
Pharmacy journal abstracts published in PubMed that abide by the CONsolidated Standards Of Reporting Trials (CONSORT) guidelines. J Med Libr Assoc (2014) 0.80
A review of spin and bias use in the early intervention in psychosis literature. Prim Care Companion CNS Disord (2014) 0.79
Titles versus titles and abstracts for initial screening of articles for systematic reviews. Clin Epidemiol (2013) 0.78
The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignancies. Leukemia (2016) 0.77
Use of adjectives in abstracts when reporting results of randomized, controlled trials from industry and academia. Drugs R D (2015) 0.75
Spin and bias: the tip of the iceberg. Ann Oncol (2013) 0.75
Spin and bias: the tip of the iceberg. Ann Oncol (2013) 0.75
Kidney transplantation under FK 506. JAMA (1990) 7.45
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
The relation between cell proliferation and the vascular system in a transplanted mouse mammary tumour. Br J Cancer (1968) 4.88
Nucleic acid reactivity and conformation. II. Reaction of cytosine and uracil with sodium bisulfite. J Biol Chem (1973) 4.44
a controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med (2000) 4.15
X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet (2001) 3.86
The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med (2001) 3.85
The impact of conversion from prograf to generic tacrolimus in liver and kidney transplant recipients with stable graft function. Am J Transplant (2011) 3.42
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO. J Med Genet (2004) 3.10
Deamination of cytosine derivatives by bisulfite. Mechanism of the reaction. J Am Chem Soc (1974) 2.92
Medical education and health for all. Aust J Public Health (1995) 2.65
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50
Living donor renal transplantation using alemtuzumab induction and tacrolimus monotherapy. Am J Transplant (2006) 2.48
Population kinetics of carcinoma cells, capillary endothelial cells, and fibroblasts in a transplanted mouse mammary tumor. Cancer Res (1970) 2.47
Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol (2000) 2.34
The deamination of cytidine and cytosine by acidic buffer solutions. Mutagenic implications. Biochemistry (1966) 2.30
Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J (1999) 2.28
On the reaction of guanine with glyoxal, pyruvaldehyde, and kethoxal, and the structure of the acylguanines. A new synthesis of N2-alkylguanines. Biochemistry (1969) 2.25
Unconventional therapies for cancer: a refuge from the rules of evidence? CMAJ (1998) 2.24
Overview: deinstitutionalization of psychiatric patients, a critical review of outcome studies. Am J Psychiatry (1981) 2.24
Should HLA mismatch acceptability for sensitized transplant candidates be determined at the high-resolution rather than the antigen level? Am J Transplant (2015) 2.24
A critical appraisal of methods to grade transplant glomerulitis in renal allograft biopsies. Am J Transplant (2010) 2.14
Characteristic ribonucleolytic activity of human angiogenin. Biochemistry (1986) 2.06
Perception of quality of life by patients, partners and treating physicians. Qual Life Res (2000) 2.04
Health-related quality of life in men with metastatic prostate cancer treated with prednisone alone or mitoxantrone and prednisone. J Clin Oncol (1999) 2.03
Quality of cancer care. Ann Oncol (2004) 2.01
Quantifying the risk of incompatible kidney transplantation: a multicenter study. Am J Transplant (2014) 2.00
Human polyoma virus-associated interstitial nephritis in the allograft kidney. Transplantation (1999) 1.93
The point system for organ distribution. Transplant Proc (1989) 1.88
Cancer and cancer-therapy related cognitive dysfunction: an international perspective from the Venice cognitive workshop. Ann Oncol (2007) 1.88
Experience with liver and kidney allografts from non-heart-beating donors. Transplantation (1995) 1.83
The proliferation of capillary endothelial cells. Cancer Res (1972) 1.81
Molecular recognition of human angiogenin by placental ribonuclease inhibitor--an X-ray crystallographic study at 2.0 A resolution. EMBO J (1997) 1.77
Specific acylation of the guanine residues of ribonucleic acid. J Biol Chem (1970) 1.74
Bone metastases: pathophysiology and management policy. J Clin Oncol (1991) 1.70
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU. Br J Cancer (1980) 1.68
Oxygen diffusion and the distribution of cellular radiosensitivity in tumours. Br J Radiol (1972) 1.67
Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa. Ann Oncol (2008) 1.67
How expert physicians would wish to be treated if they had genitourinary cancer. J Clin Oncol (1988) 1.65
Cryoablation of unresectable malignant liver tumors. Am J Surg (1996) 1.62
Donor-transmitted malignancies in organ transplantation: assessment of clinical risk. Am J Transplant (2011) 1.59
Inhibition of HIV infection by a novel CD4 domain 2-specific monoclonal antibody. Dissecting the basis for its inhibitory effect on HIV-induced cell fusion. J Immunol (1992) 1.58
The 'two, one, zero' decision: what to do with suboptimal deceased donor kidneys. Am J Transplant (2010) 1.58
Retreatment of patients with the same chemotherapy: implications for clinical mechanisms of drug resistance. Ann Oncol (2001) 1.57
Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor. Biochemistry (1989) 1.57
Sites of nonenzymatic glycosylation of human hemoglobin A. J Biol Chem (1980) 1.56
New onset of diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc (1991) 1.56
Regular articles: conditional disruption of hedgehog signaling pathway defines its critical role in hair development and regeneration. J Invest Dermatol (2000) 1.56
Comparison of FK-506 and cyclosporine regimens in pediatric renal transplantation. Pediatr Nephrol (1994) 1.55
Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc Natl Acad Sci U S A (1987) 1.55
Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy. Br J Cancer (2006) 1.54
Acidic hydrolysis of deoxycytidine and deoxyuridine derivatives. The general mechanism of deoxyribonucleoside hydrolysis. Biochemistry (1972) 1.54
The fate of abstracts submitted to a cancer meeting: factors which influence presentation and subsequent publication. Ann Oncol (1992) 1.54
Nosocomial outbreak of tuberculosis in a renal transplant unit: application of a new technique for restriction fragment length polymorphism analysis of Mycobacterium tuberculosis isolates. J Infect Dis (1993) 1.53
Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol (2008) 1.53
Bisulfite-catalyzed transamination of cytosine and cytidine. Biochem Biophys Res Commun (1970) 1.52
Isolation and identification of cross-links from formaldehyde-treated nucleic acids. Biochemistry (1980) 1.52
Ethical considerations for participation of nondirected living donors in kidney exchange programs. Am J Transplant (2010) 1.51
The reaction of guanine derivatives with 1,2-dicarbonyl compounds. Biochemistry (1966) 1.50
Uncatalyzed hydrolysis of deoxyuridine, thymidine, and 5-bromodeoxyuridine. Biochemistry (1969) 1.49
Pancreas transplantation with enteric drainage under tacrolimus induction therapy. Transplant Proc (1997) 1.48
The mutagenic specificity of sodium bisulfite. Biochem Biophys Res Commun (1970) 1.48
Analysis of the prognostic effects of inclusion in a clinical trial and of myelosuppression on survival after adjuvant chemotherapy for breast carcinoma. Cancer (2001) 1.47
Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol (1988) 1.45
Crystal structure of the superantigen enterotoxin C2 from Staphylococcus aureus reveals a zinc-binding site. Structure (1995) 1.42
Quality of life and/or symptom control in randomized clinical trials for patients with advanced cancer. Ann Oncol (2007) 1.42
Adverse effects associated with the use of FK 506. Transplant Proc (1991) 1.41
Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer. J Urol (2006) 1.39
Quantitative techniques for study of the anatomy and function of small blood vessels in tumors. J Natl Cancer Inst (1969) 1.39
Ciprofloxacin does not block the antiproliferative effect of tacrolimus. Transplantation (1997) 1.39
Mechanism of obstruction of the infradiaphragmatic portion of the inferior vena cava in the presence of increased intra-abdominal pressure. Invest Radiol (1966) 1.39
FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc (1991) 1.37
Diffuse skeletal abnormalities in Forestier disease. Arch Intern Med (1976) 1.37
Embryogenesis of the human occipital bone. AJR Am J Roentgenol (1976) 1.36
Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain. J Clin Oncol (2003) 1.35
Contribution of naïve and memory T-cell populations to the human alloimmune response. Am J Transplant (2009) 1.34
In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycin. Br J Cancer (1980) 1.33
The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine. Am J Surg Pathol (1993) 1.32
Improved local control of invasive bladder cancer by concurrent cisplatin and preoperative or definitive radiation. The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol (1996) 1.32
Two-year follow-up of the patients included in the WHO International Pilot Study of Schizophrenia. Psychol Med (1977) 1.32
Indomethacin-induced prostaglandin inhibition with hyperkalemia. A reversible cause of hyporeninemic hypoaldosteronism. Ann Intern Med (1979) 1.30
Structural heterogeneity of human hemoglobin A due to nonenzymatic glycosylation. J Biol Chem (1979) 1.30
Crystal structure of human angiogenin reveals the structural basis for its functional divergence from ribonuclease. Proc Natl Acad Sci U S A (1994) 1.30
Dual site model for the organogenic activity of angiogenin. Proc Natl Acad Sci U S A (1991) 1.29
Influence of vitamin A on immunological response. Immunology (1972) 1.28
BK virus infection in a kidney allograft diagnosed by needle biopsy. Am J Kidney Dis (1995) 1.28
Gemcitabine: a promising new agent in the treatment of advanced urothelial cancer. J Clin Oncol (1997) 1.25
The Danish twin register. Acta Genet Med Gemellol (Roma) (1968) 1.25
Leukotriene A4 hydrolase: determination of the three zinc-binding ligands by site-directed mutagenesis and zinc analysis. Proc Natl Acad Sci U S A (1991) 1.25
Pseudomonas folliculitis. Development after the home use of personal whirlpool spa. Cutis (1980) 1.24
Ovarian carcinomatosis presenting with hyperamylasemia and pleural effusion. Am J Gastroenterol (1981) 1.24
Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors. Clin Cancer Res (1999) 1.24
Characteristic immune abnormalities in hemophagocytic lymphohistiocytosis. J Pediatr Hematol Oncol (1996) 1.24
Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients. Ann Surg (1999) 1.24
Isolation and characterization of a human colon carcinoma-secreted enzyme with pancreatic ribonuclease-like activity. Biochemistry (1986) 1.24
Augmentation of chimerism in whole organ recipients by simultaneous infusion of donor bone marrow cells. Transplant Proc (1995) 1.24
The effect of legislative requirements on the use of breast-conserving surgery. N Engl J Med (1996) 1.24
Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates. Am J Transplant (2013) 1.22
Recipient tissue factor expression is associated with consumptive coagulopathy in pig-to-primate kidney xenotransplantation. Am J Transplant (2010) 1.21
Fine-needle aspiration biopsy in pancreatic transplantation. Transplant Proc (1995) 1.21